ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,729Medicare Part D Prescriptions Filled, Including Refills

Rank: 275 out of 1206

$391K Total Retail Price of All Prescriptions

Rank: 309 out of 1206

410 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
24% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 410 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

15% of this provider’s 410 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 7,703 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $46 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
OMEPRAZOLE 423 389 1 3
SIMVASTATIN 407 356 2 1
LEVOTHYROXINE SODIUM 376 342 3 2
LISINOPRIL 367 340 4 4
METOPROLOL TARTRATE 334 305 5 9
CITALOPRAM HBR 221 190 6 16
AMLODIPINE BESYLATE 213 202 7 6
HYDROCHLOROTHIAZIDE 208 202 8 11
ATORVASTATIN CALCIUM 206 186 9 13
METFORMIN HCL 201 177 10 10
HYDROCODONE-ACETAMINOPHEN 191 167 S3 11 7
ALENDRONATE SODIUM 187 187 12 19
FUROSEMIDE 163 154 13 5
METOPROLOL SUCCINATE 137 137 14 15
DONEPEZIL HCL 134 134 15 29
POTASSIUM CHLORIDE 132 108 16 12
WARFARIN SODIUM 129 102 17 8
PRAVASTATIN SODIUM 123 123 18 21
GLYBURIDE 118 106 R 19 69
JANTOVEN 115 115 20 95
ZOLPIDEM TARTRATE 99 82 21 25
NAMENDA 96 96 22 36
LOSARTAN POTASSIUM 87 74 23 20
CRESTOR 84 64 24 30
SERTRALINE HCL 82 63 25 22
POLYETHYLENE GLYCOL 3350 70 54 26 31
ESCITALOPRAM OXALATE 68 65 27 86
GABAPENTIN 68 58 27 18
ATENOLOL 67 50 29 14
TRAMADOL HCL 66 63 30 17
MIRTAZAPINE 63 60 31 50
TERAZOSIN HCL 61 59 32 81
CLONIDINE HCL 55 51 33 88
FLUTICASONE PROPIONATE 55 44 33 42
FLUOXETINE HCL 54 54 35 52
CLOPIDOGREL 52 50 36 48
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 3, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.